Ct-pro-vasopressin (Copeptin) is equivalent to B-type natriuretic peptide as predictor of death in patients with chronic heart failure

被引：0
|
作者：
Berger, R
Huelsmann, M
Moertl, D
Morgenthaler, NG
Struck, J
Bergmann, A
Pacher, R
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Brahms Ag, Hennigsdorf, Germany
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1725
引用
收藏
页码：U403 / U403
页数：1
相关论文
共 50 条
  • [21] B-type natriuretic peptide (BNP) in heart failure Tunisian patients
    Jaidane, Z.
    Ferchichi, S.
    Dandana, A.
    Chahed, H.
    Ben Limem, H.
    Bouraoui, H.
    Ammar, H.
    Miled, A.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2010, 25 (04): : 171 - 178
  • [22] B-type natriuretic peptide in the diagnosis and management of patients with heart failure
    Povedano, WJ
    Wahl, HG
    Passino, C
    CLINICA CHIMICA ACTA, 2005, 355 : S68 - S68
  • [23] B-type natriuretic peptide measurement in heart failure
    Spevack, DM
    Schwartzbard, A
    CLINICAL CARDIOLOGY, 2004, 27 (09) : 489 - 494
  • [24] B-type natriuretic peptide for congestive heart failure
    Wu, AHB
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (02): : 155 - 159
  • [25] B-type natriuretic peptide as a risk predictor of long-term outcomes in heart failure patients
    HCV Rey
    MI Bittencourt
    RM Rocha
    FOD Rangel
    ALC Marins
    MI Garcia
    SS Xavier
    R Esporcatte
    Critical Care, 9 (Suppl 2):
  • [26] Levels of B-type natriuretic peptide in chronic heart failure patients with and without diabetes mellitus
    Peng, Qiang
    Hu, Weitong
    Su, Hai
    Yang, Qing
    Cheng, Xiaoshu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (01) : 229 - 232
  • [27] Bedside B-type natriuretic peptide and functional capacity in chronic heart failure
    Jourdain, P
    Funck, F
    Bellorini, M
    Guillard, N
    Loiret, J
    Thebault, B
    Desnos, M
    Duboc, D
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (02) : 155 - 160
  • [28] The Concomitant Inflammation Affect the Ratio of N-terminal Pro B-type Natriuretic Peptide to B-type Natriuretic Peptide in Patients With Heart Failure and Preserved Ejection Fraction
    Kawai, Tsutomu
    Yamada, Takahisa
    Watanabe, Tetsuya
    Tamaki, Shunsuke
    Hikoso, Shungo
    Nakatani, Daisaku D.
    Yano, Masamichi
    Takaharu, Hayashi
    Nakagawa, Akito
    Nakagawa, Yusuke
    Yasumura, Yoshio
    Fukunami, Masatake
    Sakata, Yasushi
    CIRCULATION, 2020, 142
  • [29] Comparison of midregional pro-atrial natriuretic peptide, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: Influencing factors, detection of left ventricular systolic dysfunction, and prediction of death
    Moertl, Deddo
    Huelsmann, Martin
    Struck, Joachim
    Gleiss, Andreas
    Hammer, Alexandra
    Morgenthaler, Nils G.
    Bergmann, Andreas
    Berger, Rudolf
    Pacher, Richard
    CIRCULATION, 2007, 116 (16) : 620 - 621
  • [30] Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients
    Wang, Yunhong
    Zhang, Rongcheng
    Huang, Yan
    Zhai, Mei
    Zhou, Qiong
    An, Tao
    Huang, Yuhui
    Zhao, Xuemei
    Tian, Pengchao
    Zhang, Yuhui
    Zhang, Jian
    CLINICA CHIMICA ACTA, 2019, 491 : 8 - 14
12345